Endamust 100mg Injection

About

Endamust 100mg Injection contains Bendamustine, an alkylating agent with unique antimetabolite properties, primarily used in the treatment of various hematologic malignancies. It exerts its cytotoxic effects by forming highly reactive alkyl groups that cross-link DNA strands, leading to DNA damage and inhibition of DNA synthesis and repair. This dual mechanism of action, combining features of both alkylating agents and purine analogs, contributes to its efficacy against certain resistant cancer cells.

Bendamustine is particularly effective in conditions like chronic lymphocytic leukemia (CLL) and indolent non-Hodgkin lymphoma (NHL) that have progressed after initial therapy. Its distinct mechanism of action often allows it to be effective in patients who have failed other chemotherapy regimens. Administered intravenously, Endamust 100mg requires careful monitoring for myelosuppression and other potential side effects, making it a critical component in the management of specific hematological cancers under expert medical supervision.

Uses

• Treatment of chronic lymphocytic leukemia (CLL)
• Management of indolent non-Hodgkin lymphoma (NHL)
• Therapy for multiple myeloma
• Treatment of Hodgkin lymphoma

Directions For Use

Administered intravenously by a qualified healthcare professional. Dosage and infusion rate are carefully determined based on patient factors and disease.

Benefits

• Effective against resistant hematologic cancers
• Dual mechanism of action (alkylating and antimetabolite)
• Established efficacy in specific lymphomas and leukemias
• Can be used in combination therapies
• Improves progression-free survival in certain indications
• Manageable side effect profile compared to some agents

Side Effects

• Bone marrow suppression (low blood counts)
• Nausea and vomiting
• Fatigue and weakness
• Fever and chills
• Increased risk of infection
• Oral mucositis
• Skin rash
• Peripheral neuropathy
• Tumor lysis syndrome
• Infusion-related reactions
• Alopecia (hair thinning)
• Diarrhea

Safety Measures

• Alcohol - Avoid alcohol consumption during treatment as it may exacerbate side effects and potentially interact with the medication.
• Pregnancy - Contraindicated in pregnancy due to severe teratogenic and embryotoxic effects. Effective contraception is mandatory for both male and female patients.
• Breastfeeding - Contraindicated during breastfeeding as Bendamustine is likely excreted in breast milk and can cause serious adverse effects in the infant.
• Liver - Use with caution in patients with liver impairment; dose adjustment may be necessary. Liver function should be closely monitored.
• Kidney - Use with caution in patients with kidney impairment; dose adjustment may be necessary. Renal function should be regularly assessed.
• Lung - Rare cases of pulmonary toxicity, including interstitial pneumonitis and fibrosis, have been reported. Monitor for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.